Concentra Group Holdings Parent Inc Dossier - Source-backed chat

Concentra Group Holdings Parent Inc

CONNYSE

SectorHealth Care

IndustryMedical Care Facilities

Beta (adjusted)0.76

Intrinsic Value $28.92median of 6 methods · middle span $25-$87based on filings through 30 Jun 2026

Market Price $34.97Price as of 1 Oct 2026

OvervaluedIntrinsic value is 17% below the market price

−50% · IV below pricenear fair value ±15%IV above price · +50%

Data confidence Sign in to view data confidence

Market Cap $4.5B

Enterprise Value $5.9B

Shares Outstanding 128.3M diluted

Moat Rating Wide

Next Earnings Date5 Nov 2026

Last ex-dividend20 Aug 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Concentra Group Holdings Parent, Inc. (NYSE: CON) is the undisputed leader in the highly specialized and fragmented U.S. occupational health market. Following its successful spin-off from Select Medical in late 2024, Concentra operates as a pure-play leader with robust B2B relationships, high recurring revenue streams from workers' compensation, and a highly scalable platform. The company's Q1 2026 results demonstrated strong execution with double-digit revenue growth and margin expansion, supported by the successful integration of Nova Medical Centers and Pivot Onsite Innovations. With raised full-year 2026 guidance and a clear path to deleveraging below 3.0x net leverage, Concentra presents a compelling defensive growth profile with strong cash flow generation.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets8 analysts · as of 18 Aug 2026

Low · most bearish analyst$34.00

Mean target$39.88

High · most bullish analyst$42.00

Street targets sit above today's price; our intrinsic value sits below it. Different horizons, different questions.

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$34.0015%

A macroeconomic slowdown or rising unemployment rates in key industrial sectors lead to a contraction in workers' compensation and employer services visit volumes. Integration challenges or higher-than-expected labor costs for clinicians compress operating margins. Deleveraging is delayed, keeping net leverage above 3.3x and limiting capital allocation flexibility for de novo expansion or share repurchases.

Base CaseCentral scenario

$39.8860%

Matches the consensus mean

Concentra delivers on its raised FY 2026 guidance, achieving revenue between $2.275 billion and $2.375 billion and Adjusted EBITDA between $460 million and $480 million. Organic visit growth remains steady in the mid-single digits, complemented by disciplined de novo clinic openings and bolt-on acquisitions. Net leverage successfully declines below 3.0x by year-end, and the company continues its quarterly dividend payments and opportunistic share buybacks under its remaining $80 million authorization.

Bull CaseUpside scenario

$42.0025%

Accelerated consolidation of regional occupational health clinics and rapid expansion of onsite clinics drive market share gains. Synergies from the Nova and Pivot acquisitions exceed expectations, leading to Adjusted EBITDA margins expanding beyond 22%. Stronger-than-expected employment growth in industrial and service sectors boosts workers' compensation visit volumes, driving free cash flow above $250 million and enabling rapid debt paydown and increased share repurchases.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Undisputed market leadership as the largest provider of occupational health services in the United States.
Highly defensive and resilient business model with sticky B2B relationships and recurring workers' compensation revenue.
Strong cash flow generation profile, with raised FY 2026 Free Cash Flow guidance of $215 million to $235 million.
Proven consolidation playbook with successful integration of large-scale acquisitions like Nova Medical Centers and Pivot Onsite Innovations.

Key Investment Risks

Sensitivity to macroeconomic employment levels, particularly in industrial, construction, and service sectors.
High leverage post-spin-off, with total debt of approximately $2.12 billion and a net leverage ratio of 3.4x as of late 2025.
Exposure to rising clinician labor costs and potential shortages of qualified physical therapists and occupational physicians.

Thesis Invalidation Triggers

A sharp increase in the national unemployment rate that materially reduces employer-sponsored services and injury care visits.
Failure to reduce net leverage below 3.0x by the end of fiscal year 2026.
A significant decline in revenue per visit or a persistent contraction in Adjusted EBITDA margins below 19%.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.